Gujarat Terce Laboratories Faces Evaluation Shift Amid Market Challenges and Technical Weaknesses
Gujarat Terce Laboratories has recently experienced a change in its evaluation, highlighting shifts in its technical landscape. Despite a modest return since May and positive quarterly financial performance, the company faces long-term challenges, including underperformance against the broader market and concerns over its debt management.
Gujarat Terce Laboratories, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape, indicating a change in the stock's underlying trends. The company's technical indicators have shown a bearish trend, with the MACD and KST signaling a similar outlook. While the stock has generated a return of 6.41% since early May, it has faced challenges in maintaining a competitive edge in the market. Over the past year, Gujarat Terce Laboratories has underperformed relative to the broader market, which has seen positive returns.
Despite a positive financial performance in the latest quarter, the company grapples with long-term fundamental weaknesses. Its average Return on Capital Employed (ROCE) stands at 5.08%, and net sales growth has been modest at an annual rate of 6.69% over the past five years. Additionally, the high Debt to EBITDA ratio raises concerns about its ability to service debt effectively.
Overall, the adjustment in evaluation reflects the complexities surrounding Gujarat Terce Laboratories' market position and performance indicators.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
